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Abstract
During malignant neoplastic progression the cells undergo genetic and epigenetic cancer-specific alterations that
finally lead to a loss of tissue homeostasis and restructuring of the microenvironment. The invasion of cancer cells
through connective tissue is a crucial prerequisite for metastasis formation. Although cell invasion is foremost a
mechanical process, cancer research has focused largely on gene regulation and signaling that underlie uncon-
trolled cell growth. More recently, the genes and signals involved in the invasion and transendothelial migration of
cancer cells, such as the role of adhesion molecules and matrix degrading enzymes, have become the focus of
research. In this review we discuss how the structural and biomechanical properties of extracellular matrix and
surrounding cells such as endothelial cells influence cancer cell motility and invasion. We conclude that the
microenvironment is a critical determinant of the migration strategy and the efficiency of cancer cell invasion.
Introduction
The malignancy of cancer is rooted in the ability of
tumor cells to spread to distant locations in the body
and to form metastases. The formation of metastases is
a complex process involving multiple steps: first, tumor
cells must break away from the primary tumor and
invade through the surrounding tissue and its extracel-
lular matrix (ECM). Matrix invasion is one of the ear-
liest steps in the metastatic process and a key
determinant of the metastatic potential of tumor cells.
Next, the tumor cells enter the bloodstream or the
lymph vessel system which enables them to quickly and
efficiently spread to distant sites; therefore, the meta-
stasizing tumor cells must be capable of intravasation,
survival in the bloodstream or lymphatic system, and
extravasation (reviewed in [1]). Regardless of whether
extravasation takes place, however, the migration
through connective tissue (subsequently called invasion)
is a prerequisite for metastasis formation.
Although cell invasion is foremost a mechanical pro-
cess, cancer research has focused largely on gene regula-
tion and signaling that lead to uncontrolled cell growth.
More recently, the genes and signals involved in the
invasion and transendothelial migration of cancer cells,
such as the role of adhesion molecules and matrix
degrading enzymes, have become the focus of research
[2-4]. However, the mechanical processes themselves
that control cancer cell invasion, such as cell adhesion,
changes of cell shape, cell movements and motility, and
the generation of forces, are currently not well under-
stood [5-8]. We argue that the invasion process can
only be understood in the context of the cancer cells’
interactions with its environment. In this review we dis-
cuss how the structural and biomechanical properties of
the extracellular matrix and surrounding cells such as
endothelial cells influence cancer cell motility and inva-
sion strategies.
Biophysical properties of the ECM and their
influence on cancer cell motility
T h ec o n n e c t i v et i s s u ef o r m sa mechanically stable sup-
port for epithelial cells, permits the diffusion of oxygen
and nutrients between the microvasculature and adja-
cent tissues, and enables the trafficking of freely moving
cells. The connective tissue is composed of a biopolymer
fiber network of proteins, proteoglycans and glycosami-
noglycans that differ in composition and structure
throughout various parts of the body. The size of the
biopolymer fibers and the density of the fiber network
determine the mechanical, or rheological, properties as
well as the morphological properties of the ECM such
as porousness and mesh size.
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The fiber network morphology has a direct impact on
how much resistance a moving cell encounters. If the
cross-section of the migrating, elongated cell matches or
is slightly below the mesh size, then the cell encounters
no resistance, or steric hindrance. If the mesh size is too
large, the migration speed decreases [9] due to a loss of
cell-fiber attachment sites that are needed to either push
or pull the cell body forward. But as we will see below,
there are also other secondary, less direct effects of fiber
density on cell migration behavior.
Large mesh sizes make it possible that cells with a
round cell shape can migrate through the network in a
so-called amoeboid fashio n .I fo n l yv e r yf e wf i b e r s
remain, however, the cell is limited to an effective “1D”
migration mode [10]. Conversely, if the fiber density
increases such that the mesh size becomes too small,
the migration speed decreases and the cells may get
trapped [9]. Large-scale cell deformability is mostly gov-
erned by the rigidity of the nucleus which is regulated
by nuclear lamins A/C [11,12]. The cell has several
options to move through a pore that is smaller than its
cross section. The cell can either force the network
fibers apart, it can remodel its shape until it can pass
through the pore, or it can degrade the fiber matrix
with the help of proteolytic enzymes [13,14].
Matrix Rheology
The force that is needed to move the network fibers
apart and “out of the way” is determined by the
mechanical, also called rheological, properties of the
ECM. These include the frequency-, strain- and strain-
rate-dependent visco-elastic shear modulus, the strain-
dependent plasticity, compressibility, and Poisson-ratio.
These mechanical parameters are related to the struc-
tural and molecular properties of the tissue, in particular
collagen content, fiber thickness, and the extent of intra-
fibrillar cross-links [15].
Mechanosensing
On the one hand, fiber pore size and mechanical proper-
ties determine the passive steric hindrance of the ECM.
On the other hand, ECM mechanical properties are
sensed by the cell and can lead to an active adaptation so
that cells may increase their protrusive forces to compen-
sate for increased steric hindrance of the matrix. This
mechano-sensing is facilitated by integrin-mediated
adhesions and downstream mechanosensor protein sig-
naling (i.e., via vinculin, talin, FAK, p130CAS and filamin
A; [16-20]. Increased stiffness of the surrounding ECM
evokes a reinforcement of focal adhesions and increased
RhoA-mediated actomyosin contraction, ultimately lead-
ing to cell protrusions, high-traction forces, and elon-
gated cell shapes [21]. Conversely, a soft matrix does not
lead to focal adhesion reinforcement and cytoskeletal
contractility; rather, it encourages cell rounding [22]. In
this way, tissue rigidity can stimulate directed cell migra-
tion as potently as the presence of a chemotactic gradi-
ent. In particular, cells tend to move toward regions of
greater stiffness, a process known as durotaxis [23].
The mechanical ECM properties can be changed and
remodeld by the activity of tumor cells. Such ECM
remodeling leads to the characteristic stiffening of the
tumor tissue. The importance of ECM remodeling for
cancer progression becomes in c r e a s i n g l ym o r ea p p r e -
ciated. Recently, Leventhal and co-authors reported that
breast tumorigenesis is accompanied by collagen cross-
linking, ECM stiffening, and increased focal adhesion
formation [24]. Induction of collagen crosslinking stif-
fened the ECM, promoted focal adhesions, enhanced
PI3 kinase activity, and induced the invasion of an onco-
gene-initiated epithelium. In contrast, the inhibition of
integrin signaling repressed the invasion of a premalig-
nant epithelium. Consistently, reduced matrix stiffness
by a reduction of lysyl oxidase-mediated collagen cross-
linking impeded malignancy and lowered tumor inci-
dence [24].
Contact guidance
Connective tissues show different fiber arrangements
that can range from loose or random to highly aligned
structures [25,26]. Cancer cells display an aligning beha-
vior, called contact guidance, [27] and orient themselves
along these structural ECM elements [28]. Contact gui-
dance is mediated by mechanosensory integrins that,
together with Rho/ROCK-mediated cytoskeletal orienta-
tion and directional contraction, enable the directional
persistence in cell invasion [28]. Conversely, matrix fiber
alignment and reorganization is also cell contractility-
dependent and mediated by Rho/Rho kinase pathway
activity [28]. But even when Rho or Rho kinase path-
ways are inhibited, 3 D cell migration is still enhanced
by fiber alignment.
In summary, the structural and mechanical properties
of the ECM have a substantial impact on cell behavior.
They modulate cell adhesions, cytoskeletal reorganiza-
tion and cell shape, and through contact guidance
mechanisms lead to directed cell migration that is essen-
tial for tumor spreading, transendothelial migration and
metastasis formation.
Mechanisms of cancer cell migration through
connective tissue
In the following, we take a closer look at the process of
cancer cell invasion and the different mechanisms and
strategies that cancer cells employ to move through
connective tissue. Tumor cells can migrate either collec-
tively, retaining their intracellular junctions, or
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motile individually migrating cells is an intensively stu-
died process known as epithelial-mesenchymal transition
(EMT). EMT is induced by repression of transcriptional
regulators such as Snail or Twist which leads to down-
regulation of E-cadherin and consequently to loss of
intercellular junctions (reviewed in [1]). Individual cell
migration strategies are broadly classified as either
mesenchymal or amoeboid (for a review see [29]). Yet
the amoeboid and mesenchymal invasion modes are not
mutually exclusive, and the suppression or enhancement
of specific molecular pathways can induce a mesenchy-
mal-amoeboid transition or amoeboid-mesenchymal
transition (Figure 1). While an epithelial-mesenchymal
transition is accompanied by extensive alterations in
gene transcription and therefore is a relatively slow pro-
cess, cells can switch rapidly, even within minutes,
between amoeboid and mesenchymal invasion strategies,
depending on the local ECM environment. However, it
should be noted that the bidirectional mesenchymal-
amoeboid transition was shown only in vitro, and its
relevance in vivo has yet to be confirmed.
Mesenchymal invasion
The mesenchymal type of cell migration resembles fibro-
blast-like motility and is shared, apart from fibroblasts,
by keratinocytes, endothelial cells, macrophages and
many tumor cells types. Cells with a mesenchymal type
of motility exhibit an elongated spindle-like shape with
one or more leading pseudopods. Movement of the
mesenchymally migrating cells is initiated by the forma-
tion of actin-rich filopodia and lamellipodia at the leading
edge. This process is controlled by the small Rho-
GTPases Rac and Cdc42 [30,31]. What then follows is a
cycle of adhesion to the ECM, stress fiber formation, con-
traction, and detachment at the rear end of the cell [32].
Moreover, integrin clustering at the leading edge and the
associated adhesion structures recruit ECM-degrading
enzymes such as MT1-MMP (membrane-type 1 matrix
metalloproteinase), cathepsins, and the complex of uroki-
nase-type plasminogen activator (uPA) and its receptor
(uPAR), to generate a path for cell migration through an
otherwise too dense ECM (Figure 2) [33-35].
Amoeboid invasion
The term amoeboid migration is inferred from the moti-
lity of amoeba, which is characterized by cycles of
expansion and contraction of the cell body and bleb-like
protrusions mediated by cortically localized actin-myo-
sin interactions [36]. Amoeboid-like movement in higher
eukaryotes has been observed and described in leuko-
cytes [37,38] and many types of tumor cells [4,39-42].
Tumor cells that exhibit an amoeboid mode of migra-
tion usually show a rounded shape in 3 D substrates.
Figure 1 Transitions among cell invasion modes. The conversion from epithelial cells to motile mesenchymally migrating cells (EMT) is
induced by repression of transcriptional regulators such as Snail or Twist which leads to a downregulation of E-cadherin and consequently to a
loss of intercellular junctions. Invasion of individual mesenchymal cells is dependent on proteolytical degradation of the surrounding ECM. The
degradation processes localize at the anterior edge of the cell and eventually generate a path for invasion. When integrin activation or
extracellular protease activity is decreased in mesenchymal cells, or when Rho/ROCK signaling is upregulated, a transition towards amoeboid
movements (MAT) occurs. Conversely, inhibition of Rho/ROCK signaling may result in amoeboid mesenchymal transition (AMT). The
mesenchymal cells exhibit elongated morphology in a 3 D environment, with actomyosin contractile units located at the front and rear of the
cells, while amoeboid cells typically exhibit a round shape in 3 D matrices, with a more cortical distribution of actomyosin fibers.
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The enhanced contractility of cells that use amoeboid-
like invasion strategies is facilitated by the activation of
the Rho/ROCK pathway and increased phosphorylation
of MLC [39,40]. Cortical acto-myosin contraction
enables the cells to squeeze through gaps and holes in
the ECM structure and to adapt their body shapes to
the pre-existing spaces. Thus, unlike path-creating
mesenchymally migrating cells, amoeboid cells can be
described as path-finding [4,4,37,38]. Amoeboid-like
motility requires little or no receptor-facilitated adhesion
to the ECM. Moreover, it has been suggested that amoe-
boid cells could exert sufficient protrusive “pushing”
forces to deform the surrounding ECM [28,40,41].
Matrix remodeling
For a long time, the proteolytic remodeling of ECM by
matrix metalloproteinases (MMPs), serine proteases and
cathepsins was considered to be a critical determinant
of tumor cell invasiveness. Recent data, however,
demonstrate that amoeboid-like invasion is proteases-
independent [4,40]. In fact, several lines of evidence
suggests that cells can undergo a mesenchymal-to amoe-
boid transition after blocking of pericellular proteolysis
[4,39] or blocking of integrins [43]. For instance,
mesenchymally migrating HT-1080 fibrosarcoma cells
are still able to invade a 3 D collagen matrix after treat-
ment with an inhibitor cocktail that blocked ECM pro-
teolysis. After treatment, these cells show the typical
features of amoeboid invasiveness such as rounded mor-
phology and the use of cortical actomyosin contraction
during migration [4,40,44]. The induced amoeboid
migration of HT-1080 cells after the inhibition of pro-
teolysis is associated with a decreased cell surface
expression of a2b1 integrins and a decrease in phos-
phorylation of focal adhesion kinase (FAK) [44], suggest-
ing a lower requirement for the formation and signaling
from focal adhesions. Low affinity adhesions to the sub-
strate and independence on proteolytic degradation of
the surrounding ECM enables the amoeboid cells to
move in a 3 D environment at relatively high velocities,
ranging from 2 μm/min as observed in A375m2 mela-
noma cells [39] to 25 μm/min, which is also the maxi-
mum migration velocity of lymphocytes observed in
collagen gels [45]. The failure of MMP inhibitors in
recent clinical trials to prevent cancer progression points
to the possibility that protease independent mechanisms
of invasion may be clinically relevant (reviewed in [46]).
Alternatively, non-proteolytic functions of MMPs, the
involvment of other proteases than MMPs, or adverse
reactions to the inhibitors could also explain this
observation.
Influence of the ECM
Besides blocking of proteolysis and integrins, also the
architecture of the ECM, in particular the spatial organi-
zation of the collagen fibers, can determine the mode of
invasion [28]. To mimic the invasion of tumor cells
from the primary tumor into the surrounding matrix,
carcinoma cells can be seeded at high cell densities into
3 D collagen gels, and small pieces of this gel-cell mix-
ture are then transplanted into fresh, isotropic, cell-free
collagen gels [28]. Under such conditions, the invasion
of MDA-MB-231 breast carcinoma cells into the sur-
rounding gel has been reported to be amoeboid-like,
protease-independent and driven by Rho/ROCK-
mediated contractility. When the gel-cell explants were
transplanted into anisotropic collagen gels with aligned
fibers and presumably higher stiffness, however, the
carcinoma cells migrated in a mesenchymal fashion [28].
ECM architecture-dependent invasion modes have
also been observed in human macrophages that either
use the amoeboid migration mode in fibrillar collagen-I,
or the mesenchymal migration mode in Matrigel and
gelled collagen [47]. When migrating mesenchymally in
3 D, the macrophages form proteolytic structures at the
tips of cell protrusions that resemble podosome-type
adhesion structures. Moreover, when infiltrating
matrices of similar composition but with variable stiff-
ness, macrophages adapt their migration mode primarily
to the matrix architecture [47].
The relative importance of protease-dependent and
-independent invasion modes of cancer cell invasion
through interstitial barriers remains a subject of consid-
erable debate. Recently, it has been suggested that the
amoeboid invasiveness of tumor cells can only occur
under specific conditions that rarely occur in vivo,a n d
may not be as effective as mesenchymal cell migration
for overcoming the steric hindrance of dense and rela-
tively stiff connective tissue [4,26,39,40]. For instance, the
invasiveness of amoeboid HT-1080 and MDA-MB-231
Figure 2 Scanning electron microscopy image of
mesenchymally invading cells. K4 sarcoma cells were seeded on
the acellular dermis [74] in the absence (left) or presence (right) of a
broad-spectrum MMP-inhibitor (GM6001). In the absence of the
inhibitor, K4 cells extensively degrade the matrix, whereas in the
presence of the inhibitor they are not able to invade, and the
matrix remains mostly intact.
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in stiff matrices derived from intact full-length collagen
gels as compared to softer pepsin-extracted collagens.
The authors conclude that MT1-MMP-independent
invasion can only proceeds when the structural pores
formed in collagen gel networks are no longer stabilized
by the covalent transglutaminase cross-links that nor-
mally determine fibril architecture and structural rigidity
in full-length collagen. It would be interesting, however,
to repeat these experiments with tumor cells that use an
amoeboid mode as their primary invasion strategy.
Endothelial transmigration
How quickly cancer cells are able to migrate through
connective tissue in vivo is still debated. In vitro, migra-
tion speeds of up to 25 microns per minute through col-
lagen networks have been reported [45]. It is
conceivable that cancer cells may actually have years of
time during which they can travel for instance along
neuronal pathways to distant sites. Such metastatic can-
cer cells may lie dormant at those sites for a long time
until they spring to action and proliferate quickly. The
more common view, however, is that cancer cell migra-
tion through connective tissue is too slow and undir-
ected to account for the quick spreading and metastasis
f o r m a t i o ns e e ni nm a n yt u m o r s .I n s t e a d ,t h ec a n c e r
cells can spread much more quickly and efficiently via
lymph or blood vessels to distant sites. Thus, the cancer
cells only need to migrate through connective tissue
until they reach the nearest blood or lymph vessel
[48-50] and then to transmigrate through the endothe-
lial lining and the basement membrane [51-56].
Role of the endothelium
The endothelial lining and the basement membrane
form a passive physical barrier such that the process of
intravasation is a potentially time-consuming and rate-
limiting step in metastasis formation [50,51,57-59]. But
the endothelium can also take an active part in this pro-
cess and can either support or suppress cancer cell
adhesion and possibly their transmigration [53-55,60,61].
How exactly the endothelium functions in this process,
however, is still elusive and under investigation. In parti-
cular the mechanisms by which cancer cells can trans-
migrate through the endothelial lining are not well
understood.
Cell-cell signaling
What seems certain, however, is the existence of a
crosstalk between cancer cells and endothelial cells. The
presence of cancer cells can induce the upregulation of
adhesion molecule expression by the endothelium [62],
the reorganization of the endothelial acto-myosin cytos-
keleton [63], and Src-mediated disruption of endothelial
VE-cadherin-b-catenin cell-cell adhesions [52]. These
processes may either enable paracellular transmigration
through the formation of “holes” within the endothelial
monolayer [64] and through the induction of endothelial
cell apoptosis [65], or they enable transcellular transmi-
gration through regional modulation of cortical acto-
myosin generated tension [66].
Signals from cancer cells
The transmigration process of cancer cells seems to a
great extent resemble that of leukocytes. For example,
the normal function of the endothelial lining as a barrier
against both leukocyte trafficking and cancer cell trans-
migration [67] is reduced in the presence of inflamma-
tory cytokines such as tumor necrosis factor-a and
interleukin-1b [53,62,68,69]. These and other cytokines
promote transmigration and invasion by several
mechanisms. First, the adhesion molecule E-selectin is
upregulated in endothelial cells [62] upon exposure to
cytokines. The upregulation of E-selectin subsequently
leads to adhesion of leukocytes and cancer cells through
E-selectin ligands. Moreover, the adhesion of these cells
induces an upregulation of the stress-activated protein
kinase-2 (SAPK2/p38) in endothelial cells [62] and
induces actin polymerization and stress fiber reorganiza-
tion [63]. Second, cytokine exposure directly causes
cytoskeletal rearrangements in endothelial cells as well
as cancer cells and leukocytes, which may prime them
for efficient migration. Third, cytokine gradients lead to
a more efficient directional migration and invasion in
leukocytes [70,71] and cancer cells [72].
Signals from endothelial cells
It has been recently shown that the endothelial cells
themselves are a significant source of chemokines such
Gro-b and IL-8 [61]. These chemokines lead to
enhanced contractile force generation, cytoskeletal
remodeling, and thereby enhanced transmigration and
invasion efficiency in cancer cells with high expression
levels of the Gro-b and IL-8 receptor CXCR2 [61]. Even
more surprisingly, the amount of chemokine secretion
by the endothelial cells was greatly modulated by the
presence of some but not all cancer cells. This cross-
talk between cancer cells and endothelial cells may be in
part responsible for the “homing” of certain cancer cell
types to specific organs [61].
The reverse process of extravasation, in contrast, need
not be a rate-limiting step in metastasis formation since
at least some types of cancer cells can adhere and grow
within vessels and do not need to extravasate to induce
angiogenesis and to form secondary tumors [73]. Even
so, the endothelial cells may still impact tumor growth
by modulating cancer cell adhesion and by secreting
chemokines and growth factors.
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The structural and mechanical properties of extracellu-
lar matrix and the presence of signaling molecules from
embedded cells have a profound influence on cancer
cell motility, tissue invasion, transendothelial migration
and metastasis formation. Cancer cells react to their
environment through the modulation of cell adhesions,
contact guidance, cytoskeletal reorganization, cell shape
changes, secretion of proteolytic enzymes and chemo-
kines, and force generation. From insights in this pro-
cess we expect the development of novel cancer
therapies that target the process of metastasis formation
by interfering with the ability of cancer cells to transmi-
grate into blood and lymph vessels and to invade the
connective tissue. Cell-matrix-interactions in a 3-dimen-
sional environment, however, are currently not well
understood. This is attributable to the difficulty in gen-
erating 3-D matrices with controlled morphology, rheol-
ogy, and matrix composition, and a lack of established
methods to visualize and evaluate cell functions over
prolonged periods. Similarly, 3-D in-vitro systems to
study cancer cell interactions with other cells from the
vasculature or immune system, or even to to study 3-D
cell behavior in a well-controlled gradient of growth fac-
tors or chemokines, are largely missing. These technical
and methodological difficulties need to be urgently
s o l v e d .O n l yt h e nw i l lw eb ea b l et og a i nat h o r o u g h
understanding of the interactions between cancer cells
and their physical and biochemical environment that is
crucial for the development of novel cancer therapies.
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